| Literature DB >> 25684967 |
Kenta Baba1, Akihiko Oshita1, Mohei Kohyama1, Satoshi Inoue1, Yuta Kuroo1, Takuro Yamaguchi1, Hiroyuki Nakamura1, Yoichi Sugiyama1, Tatsuya Tazaki1, Masaru Sasaki1, Yuji Imamura1, Yutaka Daimaru1, Hideki Ohdan1, Atsushi Nakamitsu1.
Abstract
A 72-year-old woman with a sigmoid colon cancer and a synchronous colorectal liver metastasis (CRLM), which involved the right hepatic vein (RHV) and the inferior vena cava (IVC), was referred to our hospital. The metastatic lesion was diagnosed as initially unresectable because of its invasion into the confluence of the RHV and IVC. After she had undergone laparoscopic sigmoidectomy for the original tumor, she consequently had 3 courses of modified 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus cetuximab. Computed tomography revealed a partial response, and the confluence of the RHV and IVC got free from cancer invasion. After 3 additional courses of mFOLFOX6 plus cetuximab, preoperative percutaneous transhepatic portal vein embolization (PTPE) was performed to secure the future remnant liver volume. Finally, a right hemihepatectomy was performed. The postoperative course was uneventful. The patient was discharged from the hospital on postoperative day 13. She had neither local recurrence nor distant metastasis 18 mo after the last surgical intervention. This multidisciplinary strategy, consisting of conversion chemotherapy using FOLFOX plus cetuximab and PTPE, could contribute in facilitating curative hepatic resection for initially unresectable CRLM.Entities:
Keywords: Cetuximab; Colorectal liver metastasis; Conversion chemotherapy; Initially unresectable; Percutaneous transhepatic portal vein embolization
Mesh:
Substances:
Year: 2015 PMID: 25684967 PMCID: PMC4323478 DOI: 10.3748/wjg.v21.i6.1982
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742